Hyperfine, Inc. (HYPR)
0.8133
-0.02
(-2.83%)
USD |
NASDAQ |
Sep 04, 16:00
0.8299
+0.02
(+2.04%)
After-Hours: 20:00
Hyperfine Shareholders Equity (Quarterly) : 36.76M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 36.76M |
| March 31, 2026 | 34.36M |
| December 31, 2025 | 41.00M |
| September 30, 2025 | 26.87M |
| June 30, 2025 | 35.13M |
| March 31, 2025 | 43.11M |
| December 31, 2024 | 49.04M |
| September 30, 2024 | 58.32M |
| June 30, 2024 | 66.76M |
| March 31, 2024 | 75.64M |
| December 31, 2023 | 84.40M |
| September 30, 2023 | 93.77M |
| Date | Value |
|---|---|
| June 30, 2023 | 103.29M |
| March 31, 2023 | 112.74M |
| December 31, 2022 | 123.72M |
| September 30, 2022 | 134.98M |
| June 30, 2022 | 150.51M |
| March 31, 2022 | 166.56M |
| December 31, 2021 | 186.23M |
| September 30, 2021 | 198.75M |
| June 30, 2021 | 199.65M |
| March 31, 2021 | 201.08M |
| December 31, 2020 | 67.23M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Abbott Laboratories | 51.11B |
| AngioDynamics, Inc. | 170.82M |
| Alphatec Holdings, Inc. | 11.53M |
| AtriCure, Inc. | 516.43M |
| Baxter International, Inc. | 6.206B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 63.00M |
| Total Liabilities (Quarterly) | 26.24M |
| Debt to Equity Ratio | 0.3649 |
| Current Ratio | 6.152 |
| Net Debt Paydown Yield | -1.83% |